文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[老年患者化疗的机遇与局限]

[Chances and limitations of chemotherapy in elderly patients].

作者信息

Wedding U

机构信息

Klinik für Innere Medizin II, Abteilung Palliativmedizin, Universitätsklinikum Jena, Jena, Deutschland.

出版信息

Internist (Berl). 2010 Mar;51(3):402, 404-6, 408-9. doi: 10.1007/s00108-010-2601-x.


DOI:10.1007/s00108-010-2601-x
PMID:20169327
Abstract

The chronological age of a patient should not be a barrier to apply chemotherapy. Elderly patients can benefit from chemotherapy. Chronological age should not be a reason for diagnostic or therapeutic nihilism, as the age of a patient poorly characterizes their health situation. Data with high level of evidence on treatment of elderly patients with cancer are limited. A comprehensive geriatric assessment (CGA) describes the individual deficits and resources of a patient much better. Limitations in CGA are risk factors for increased toxicity and decreased treatment benefit. The currently available data demonstrate under- and over-treatment in elderly patients with cancer.

摘要

患者的实际年龄不应成为应用化疗的障碍。老年患者能够从化疗中获益。实际年龄不应成为诊断或治疗虚无主义的理由,因为患者的年龄并不能很好地反映其健康状况。关于老年癌症患者治疗的高质量证据数据有限。全面老年评估(CGA)能更好地描述患者的个体缺陷和资源。CGA的局限性是毒性增加和治疗获益降低的风险因素。目前可得的数据表明老年癌症患者存在治疗不足和过度治疗的情况。

相似文献

[1]
[Chances and limitations of chemotherapy in elderly patients].

Internist (Berl). 2010-3

[2]
Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review.

Eur Urol Focus. 2018-1-10

[3]
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.

Breast. 2013-12-5

[4]
Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly.

Acta Oncol. 2016-1

[5]
Cancer chemotherapy in elderly cancer patients.

J Oncol Manag. 2005

[6]
Tolerance to chemotherapy in elderly patients with cancer.

Cancer Control. 2007-1

[7]
Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity.

Pulmonology. 2018-9-25

[8]
Comprehensive geriatric assessment and its clinical impact in oncology.

Eur J Cancer. 2007-10

[9]
Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.

Crit Rev Oncol Hematol. 2010-7-23

[10]
[Cancer treatment in elderly patients: evidence and clinical research].

Recenti Prog Med. 2015-1

引用本文的文献

[1]
Effects of honey and its mechanisms of action on the development and progression of cancer.

Molecules. 2014-2-21

本文引用的文献

[1]
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.

Ann Oncol. 2009-8-28

[2]
Advances in the pharmacological treatment of gastro-oesophageal cancer.

Drugs Aging. 2009

[3]
Adjuvant chemotherapy in older women with early-stage breast cancer.

N Engl J Med. 2009-5-14

[4]
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

J Clin Oncol. 2009-5-1

[5]
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

J Clin Oncol. 2009-2-20

[6]
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.

J Clin Oncol. 2008-7-20

[7]
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

J Clin Oncol. 2008-7-20

[8]
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?

J Clin Oncol. 2008-5-20

[9]
Chemotherapy in elderly patients with colorectal cancer.

Oncologist. 2008-4

[10]
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Lancet. 2008-1-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索